Sign in

CIK 0001853921 · <br>Emerging growth company

Scribe Therapeutics, Inc.

Sign in to watch
Ticker
SCTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822157847
Phone
510-454-0213
Business address
1150 MARINA VILLAGE PKWY, ALAMEDA, CA, 94501
  1. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  2. 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
  3. 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
  4. 4 Conversion 10% owner acquired 12,511 shares (conversion)
  5. 4 Open-market buy Director bought 2,391,238 shares at an average $15.16 ($36,259,761)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Chief Business Officer bought 3,000 shares at $15.00 ($45,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Financial Officer bought 2,666 shares at $15.00 ($39,990)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 25 filings